Skip to content
10-Q

Quarterly Report

ProMIS Neurosciences Inc. PMN

0001104659-26-059035

← back to feed
Filed
May 12, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 12, 2026 8.97M sh
Shares Diluted Q1 2026 · Mar 31, 2026 6.53M sh
Shares Diluted restated Q1 2026 · Mar 31, 2025 1.39M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$12.38M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$4.93M
Short Term Investments Q1 2026 · Mar 31, 2026 $33.75K
Short Term Investments Q1 2026 · Dec 31, 2025 $33.75K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $63.81M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $6.12M
Stockholders Equity Q1 2026 · Mar 31, 2026 $60.72M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$1.26M
Stockholders Equity Q1 2026 · Mar 31, 2025 $9.47M
Stockholders Equity Q1 2026 · Dec 31, 2024 $16.49M
Current Liabilities Q1 2026 · Mar 31, 2026 $6.61M
Current Liabilities Q1 2026 · Dec 31, 2025 $10.41M
Total Liabilities Q1 2026 · Mar 31, 2026 $6.69M
Total Liabilities Q1 2026 · Dec 31, 2025 $10.44M
Current Assets Q1 2026 · Mar 31, 2026 $65.61M
Current Assets Q1 2026 · Dec 31, 2025 $9.18M
Total Assets Q1 2026 · Mar 31, 2026 $67.41M
Total Assets Q1 2026 · Dec 31, 2025 $9.18M
Eps Diluted Q1 2026 · Mar 31, 2026 −$1.26
Eps Diluted restated Q1 2026 · Mar 31, 2025 −$5.27
Eps Basic Q1 2026 · Mar 31, 2026 −$1.26
Eps Basic restated Q1 2026 · Mar 31, 2025 −$5.27
Sga Expense Q1 2026 · Mar 31, 2026 $1.67M
Sga Expense Q1 2026 · Mar 31, 2025 $2M
Rd Expense Q1 2026 · Mar 31, 2026 $6.97M
Rd Expense Q1 2026 · Mar 31, 2025 $5.46M
Net Income Q1 2026 · Mar 31, 2026 −$8.24M
Net Income Q1 2026 · Mar 31, 2025 −$7.35M
Operating Income Q1 2026 · Mar 31, 2026 −$8.64M
Operating Income Q1 2026 · Mar 31, 2025 −$7.46M